Can open-source R&D reinvigorate drug research?

Nat Rev Drug Discov. 2006 Sep;5(9):723-9. doi: 10.1038/nrd2131. Epub 2006 Aug 18.


The low number of novel therapeutics approved by the US FDA in recent years continues to cause great concern about productivity and declining innovation. Can open-source drug research and development, using principles pioneered by the highly successful open-source software movement, help revive the industry?

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic / methods
  • Databases, Factual*
  • Drug Approval / methods
  • Drug Design
  • Humans
  • Organizational Innovation
  • Research / organization & administration
  • Research / trends
  • Research Design*
  • Software*
  • Technology, Pharmaceutical / methods
  • Technology, Pharmaceutical / trends